The Iliac Stents Market size accounted for USD 1.15 billion in 2025 and is predicted to increase from USD 1.23 billion in 2026 to approximately USD 2.22 billion by 2035, expanding at a CAGR of 6.8% from 2026 to 2035. Iliac arterial stent placement is a harmless treatment with favourable long-term patency, which drives the growth of the market.
rnIliac vein stenting is an extension of arterial stent expertise. The stent remains in place and is intended to support keeping the artery open and prevent future tapering of the iliac artery. This stenting is a minimally invasive technology used to manage blockages or narrowing in the iliac veins, which are the huge veins located in the pelvis that return blood from the legs to the heart. This technology is often used to manage a condition known as iliac vein compression syndrome. The process includes inserting a small, elastic catheter into the femoral vein in the groin and easing it up to the site of the blockage in the iliac vein via X-ray guidance.
rnRecent advancements in metal self-expanding stents manufacturing from nitinol (NiTi) have shown shape memory and superplastic behaviours. Next-generation self-expanding stents are potentially advancing vascular intervention by addressing the limits of traditional balloon-expandable stents, specifically in complex, tortuous, or narrowing vessels. Advanced designs have evolved, some balloon expandable, but also self-expandable, based on the premise that nitinol-based designs conform more favourably than other metals to non-tubular vascular structures like bifurcations.
rn| Region | rnDeath Rate | rn
| U.S. | rn224.3 | rn
| Global | rn235.2 | rn
In 2025, North America dominated the iliac stents market with a share of 38% in 2025, as the presence of advanced hospitals and favourable reimbursement policies facilitated the extensive use of costly and specialized stents. Advanced self-expandable stents that increase vessel patency and lower restenosis.
rnAsia Pacific held 22% share of the market. expected to fastest growth with 8.2% CAGR during the forecast period, as rising cases of coronary artery disease and peripheral artery disease, driven by deskbound lifestyles, are increasing the demand for stenting. Growing preference for minimally invasive vascular actions compared to traditional operations, which lowers recovery time and hospital stays.
rnThe top five organizations in this group dominate the iliac stents market. Meanwhile, Medtronic Plc provides the Abre venous self-expanding stent and other peripheral vascular services. Abbott Laboratories, a popular manufacturer of self-expanding stents, following the acquisition of Cardiovascular Systems Inc., Boston Scientific Corporation, produces the Wallstent-Uni Endoprosthesis for iliac-vein indications. Becton Dickinson and Company (BD) is advancing peripheral interventional technologies. Terumo Corporation manufactures dedicated peripheral vascular products.
rnBy Product Type
rnBy Material
rnBy Indication
rnBy End User
rnBy Region
rn
